We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Flu vaccines available for the 2025 to 2026 flu season and the clinical risk groups that they apply to.
Guidance for custodial and healthcare teams in secure settings, NHS tuberculosis (TB) services and UK Health Security Agency (UKHSA) health protection teams.
Patient group direction (PGD) template to support the provision of MenB vaccine to individuals with underlying medical conditions.
Guidance for public health professionals to manage scabies cases and outbreaks, including recommendations for diagnosis, treatment and wider control measures.
Anthrax immunisation information for public health professionals, including updates.
Guidance on the most effective methods of prevention and control of Clostridioides difficile infection. This guidance is currently under review. Some sections of this guidance have been withdrawn.
Patient group direction (PGD) template to support the provision of MenACWY vaccine to individuals with underlying medical conditions.
Clinical advice on the diagnosis of Oropouche virus disease.
Guidance for healthcare practitioners on the hexavalent vaccine programme, including its use in the selective neonatal hepatitis B programme.
Information on taking, submitting and processing clinical samples from patients suspected of having zoonotic (acquired from birds or mammals) influenza A of any subtype.
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
Guidance on the use of personal protective equipment (PPE) for non-aerosol generating procedures (APGs).
Plain English and Easy-read guides providing information on influenza (flu) and vaccination.
These guidelines on the prevention of secondary cases have been developed following a review of the epidemiology of invasive Hib disease.
Comprehensive guidance on HPV vaccination programmes.
Information for healthcare practitioners on the changes to the infant pneumococcal vaccination schedule.
Guidance to support NHS Trusts in managing the de-isolation and discharge of mpox-infected patients.
The characteristics, symptoms and epidemiology of parvovirus B19 (also known as slapped cheek syndrome, fifth disease, or erythma infectiosum).
Information on C. auris, how it can spread, how patients are tested and treated, and what people who are carrying it can do to help prevent spreading it.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).